Xpert Ultra versus Xpert MTB/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis-Reference-Cited by-同舟云学术

Xpert Ultra versus Xpert MTB/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis

Published:2021-02-22 Issue:5 Volume:2021 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Zifodya Jerry S¹,Kreniske Jonah S²,Schiller Ian³,Kohli Mikashmi⁴,Dendukuri Nandini³,Schumacher Samuel G⁵,Ochodo Eleanor A⁶⁷,Haraka Frederick⁸⁹,Zwerling Alice A¹⁰,Pai Madhukar⁴,Steingart Karen R¹¹,Horne David J¹²

Affiliation:

1. Department of Medicine, Section of Pulmonary, Critical Care, & Environmental Medicine ; Tulane University; New Orleans LA USA

2. Department of Internal Medicine; Tulane University School of Medicine; New Orleans Louisiana USA

3. Centre for Outcomes Research; McGill University Health Centre - Research Institute; Montreal Canada

4. Department of Epidemiology, Biostatistics and Occupational Health; McGill University; Montreal Canada

5. FIND; Geneva Switzerland

6. Centre for Evidence-based Health Care, Department of Global Health, Faculty of Medicine and Health Sciences; Stellenbosch University; Cape Town South Africa

7. Centre for Global Health Research; Kenya Medical Research Institute; Kisumu Kenya

8. Elizabeth Glaser Pediatric AIDS Foundation; Dar es Salaam Tanzania

9. Ifakara Health Institute; Bagamoyo Tanzania

10. School of Epidemiology & Public Health; University of Ottawa; Ottawa Canada

11. Honorary Research Fellow; Department of Clinical Sciences, Liverpool School of Tropical Medicine; Liverpool UK

12. Department of Medicine, Division of Pulmonary and Critical Care Medicine, and Firland Northwest TB Center; University of Washington; Seattle WA USA

Publisher

Wiley

Subject

Pharmacology (medical)

Reference395 articles.

1. Performance of Xpert MTB/RIF, Xpert Ultra, and Abbott RealTime MTB for diagnosis of pulmonary tuberculosis in a high-HIV-burden setting;Berhanu;Journal of Clinical Microbiology,2018

2. The new Xpert MTB/RIF Ultra: improving detection of Mycobacterium tuberculosis and resistance to rifampin in an assay suitable for point-of-care testing;Chakravorty;Molecular Biology,2017

3. Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study;Dorman;Lancet Infectious Diseases,2018

4. Xpert Ultra and Xpert MTB/RIF for tuberculosis diagnosis in an HIV-endemic setting with a high burden of previous tuberculosis: a two cohort diagnostic accuracy study;Mishra;Lancet Respiratory Medicine,2020

5. Xpert Ultra and Xpert MTB/RIF for tuberculosis diagnosis in an HIV-endemic setting with a high burden of previous tuberculosis: a two cohort diagnostic accuracy study;Mishra;Lancet Respiratory Medicine,2020

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic accuracy of Xpert MTB/RIF and Xpert ultra tests in pulmonary and extrapulmonary tuberculosis compared to Löwenstein-Jensen culture;Clinical Epidemiology and Global Health;2024-09

2. Performance evaluation of the Xpert MTB/XDR test for the detection of drug resistance to Mycobacterium tuberculosis among people diagnosed with tuberculosis in South Africa;Journal of Clinical Microbiology;2024-08-14

3. ISCCM Position Statement on the Approach to and Management of Critically Ill Patients with Tuberculosis;Indian Journal of Critical Care Medicine;2024-08-10

4. Analysis of unsuccessful tests and the effect of prolonged clinical sample preprocessing in the GeneXpert MTB/RIF assay;BMC Infectious Diseases;2024-08-01

5. Accuracy of cobas MTB and MTB-RIF/INH for Detection of Mycobacterium tuberculosis and Drug Resistance;The Journal of Molecular Diagnostics;2024-08